Clovis Oncology
CLVS
#10878
Rank
S$15.18 M
Marketcap
S$0.10
Share price
0.00%
Change (1 day)
-95.14%
Change (1 year)

Clovis Oncology (CLVS) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : S$0.98 Billion

According to Clovis Oncology's latest financial reports the company's total liabilities are S$0.98 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Clovis Oncology - Total liabilities on balance sheet (from 2010 to 2022)

Total liabilities by year

Year Total liabilities Change
2021-12-31S$1.01 B0.5%
2020-12-31S$1.01 B-11.12%
2019-12-31S$1.13 B16.13%
2018-12-31S$0.97 B99.26%
2017-12-31S$0.49 B-7.74%
2016-12-31S$0.53 B-8.73%
2015-12-31S$0.58 B-2.8%
2014-12-31S$0.60 B212.41%
2013-12-31S$0.19 B1157.95%
2012-12-31S$15.28 M1.28%
2011-12-31S$15.08 M-85.53%
2010-12-31S$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$149.49 B 15,056.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$149.16 B 15,022.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$181.88 B 18,339.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$139.05 B 13,997.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$84.44 B 8,461.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
BioMarin Pharmaceutical
BMRN
S$6.96 B 606.42%๐Ÿ‡บ๐Ÿ‡ธ USA